Updated clinical practice guidelines for the prevention and treatment of mucositis.
about
Interventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentOral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practiceOral Mucositis Induced By Anticancer TherapiesExpert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UKSupportive cryotherapy: a review from head to toeMammalian target of rapamycin inhibitor-associated stomatitisOral and dental considerations in pediatric leukemic patientOral complications in hematopoietic stem cell recipients: the role of inflammationGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectivePharmacotherapy for adverse events reduces the length of hospital stay in patients admitted to otolaryngology ward: a single arm intervention studyInterdisciplinary care programme to improve self-management for cancer patients undergoing stem cell transplantation: a prospective non-randomised intervention study.Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: a review of current data.Low-level laser therapy: a standard of supportive care for cancer therapy-induced oral mucositis in head and neck cancer patients?Treatment of oral mucositis pain following radiation therapy for head-and-neck cancer using a bioadhesive barrier-forming lipid solutionUnderstanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitorsDouble-blind randomized study of oral glutamine on the management of radio/chemotherapy-induced mucositis and dermatitis in head and neck cancerPro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositisLow level laser therapy in oral mucositis: a pilot study.Management of Chemoradiation-Induced Mucositis in Head and Neck Cancers With Oral Glutamine.Complementary strategies for the management of radiation therapy side effectsA systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis.Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis.Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in miceThe Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools."Coffee plus honey" versus "topical steroid" in the treatment of chemotherapy-induced oral mucositis: a randomised controlled trialMASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.Effects of professional oral health care on reducing the risk of chemotherapy-induced oral mucositisOral complications of cancer and cancer therapy: from cancer treatment to survivorship.Adverse event management of oral mucositis in patients with breast cancerPrevention and management of mucositis in patients with cancer: a review articleOral care in Brazilian bone marrow transplant centersBiomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases.L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation.Parents and children's perceptions of distress related to oral mucositis during haematopoietic stem cell transplantation.Herbal substance, acteoside, alleviates intestinal mucositis in mice.Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.Oral toxicity produced by chemotherapy: A systematic review.TLR signaling modulates side effects of anticancer therapy in the small intestine.
P2860
Q24235217-CE98CFBB-4562-490C-9008-FAA6B5A28F68Q24235482-AF5C060A-2E56-4D3D-8293-A9D354D7755EQ26743390-FA6A8302-8ACE-4741-B5F9-3F45D9F14AD0Q26777493-446F71C0-09C4-455D-B786-75EECE7D271CQ26799390-5B09966A-BACA-49D4-BBC5-AE4D479D6112Q26825182-500FA6B0-98ED-4199-824F-5918CA7FCA3CQ26825301-4194F0D5-2CBF-46DA-8BCB-7F191D3043A3Q27000488-110D8693-F83F-47C2-9F93-5C8BF6843E1EQ27027650-90BF8EF4-06EF-4227-8C1F-5D0FB7F342D1Q28388806-2FCC7BC5-DC73-4EE0-A975-7AE52502652DQ28542923-C0DA438B-7F57-40E3-BCCC-6A4312BD5819Q30315577-27317DA2-97C3-40A5-9B8D-4859D7099CD2Q30639590-E6B59A89-5078-4495-A0FA-2E637F69E585Q31151263-1A99F9CB-404F-488D-A9D4-49BFCA007B8CQ33561275-6BFC62FE-732A-47D3-A6AD-B29D3451B96AQ33698419-7623E1C6-A986-4379-BB48-63E71A6C819AQ33748313-2435118F-7C03-4E7C-87A6-8359831B4DA7Q33753588-5CCC0E22-0D43-486C-8098-F4EC61020E65Q33865374-9BF71D5D-EB4A-43C6-B76F-7D52B1B07B71Q33872786-34D2E60E-94C5-4E05-88DA-7B67A23300EFQ33886006-FBCA680A-E2E8-43C2-9381-2D120045540CQ33928843-BD1C5411-B617-4FE1-9129-71E310A778E2Q33973916-E3D4C5F9-E1E4-42C1-B3A9-36957C0BB24AQ34080590-2343BCD9-05CB-46DF-900F-7F4BA150E602Q34095827-A8E92DC0-3E66-4F83-93B9-8DF5B7FD87A3Q34116283-EB83C9C8-D633-4C8F-BD17-5DACB71194EAQ34180792-E81BBC52-EF06-40D1-A137-6679ED44777DQ34283841-ECDA3E81-B138-4B5E-BB00-2C38190A9996Q34299445-F487DFF3-6412-485B-80EE-335D6487E081Q34403510-C4E0B921-4CDB-41C9-80B1-FED992882F58Q34405281-F96CF167-26CC-429F-AA38-927683090408Q34531124-93A4A57E-4CEE-42BF-A690-F9549B8C310AQ34581943-82E168E0-8B1C-44E6-99AF-7F4D34418B76Q34626107-06131391-CA75-4B5A-B6A3-46284D8AAF84Q34692009-1F90F5F1-0F64-4B91-B21E-5C4F592F5FCEQ34865540-5A02F6C3-C906-4DEA-8D35-608CF92F10D1Q34988751-6A78BB29-65B1-4E67-8AA8-AF435CC0434DQ35083960-599EBD0F-B220-4D47-B71A-579AAB068B94Q35111608-2942341E-7191-4FD0-B1DB-C8F960086C97Q35114570-BD6B8221-8B88-4C71-BED5-0286F58DA4A1
P2860
Updated clinical practice guidelines for the prevention and treatment of mucositis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Updated clinical practice guidelines for the prevention and treatment of mucositis.
@ast
Updated clinical practice guidelines for the prevention and treatment of mucositis.
@en
type
label
Updated clinical practice guidelines for the prevention and treatment of mucositis.
@ast
Updated clinical practice guidelines for the prevention and treatment of mucositis.
@en
prefLabel
Updated clinical practice guidelines for the prevention and treatment of mucositis.
@ast
Updated clinical practice guidelines for the prevention and treatment of mucositis.
@en
P2093
P356
P1433
P1476
Updated clinical practice guidelines for the prevention and treatment of mucositis.
@en
P2093
Cesar A Migliorati
Deborah B McGuire
Dorothy M Keefe
Douglas E Peterson
Joel B Epstein
Judith E Raber-Durlacher
Linda S Elting
Mark M Schubert
Mucositis Study Section of the ...... onal Society for Oral Oncology
Ronald D Hutchins
P304
P356
10.1002/CNCR.22484
P407
P577
2007-03-01T00:00:00Z